Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Leukemia, Myeloid, Acute × Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neuroblastoma 1 Neoplasms, Nerve Tissue 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Breast Neoplasms 1

Interventions

Cytarabine 22 Azacitidine 17 fludarabine phosphate 13 fludarabine 13 Cyclophosphamide 11 venetoclax 7 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Methotrexate 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 6 Whole-Body Irradiation 5 Idarubicin 5 Decitabine 5 Cyclosporine 5 decitabine and cedazuridine drug combination 4 Radiotherapy 4 Mycophenolic Acid 4 Injections 4 Daunorubicin 4 CPX-351 4 midostaurin 3 magrolimab 3 gilteritinib 3 Tacrolimus 3 Stem Cell Transplantation 3 Nivolumab 3 Mitoxantrone 3 Melphalan 3 Dasatinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01483274 2017-05-09

AML

University of Louisville

Phase 1 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡